001465083 000__ 08086nam\\22005413i\4500
001465083 001__ 1465083
001465083 003__ MiAaPQ
001465083 005__ 20230702003429.0
001465083 006__ m\\\\\o\\d\\\\\\\\
001465083 007__ cr\cn\nnnunnun
001465083 008__ 230628s2022\\\\xx\\\\\\o\\\\\|||\0\eng\d
001465083 020__ $$a9789815050561
001465083 020__ $$z9789815050578
001465083 035__ $$a(MiAaPQ)EBC7014636
001465083 035__ $$a(Au-PeEL)EBL7014636
001465083 035__ $$a(OCoLC)1330933226
001465083 040__ $$aMiAaPQ$$beng$$erda$$epn$$cMiAaPQ$$dMiAaPQ
001465083 1001_ $$aDilnawaz, Fahima.
001465083 24510 $$aArtificial Intelligence Based Cancer Nanomedicine :$$bDiagnostics, Therapeutics and Bioethics.
001465083 250__ $$a1st ed.
001465083 264_1 $$aSingapore :$$bBentham Science Publishers,$$c2022.
001465083 264_4 $$c©2022.
001465083 300__ $$a1 online resource (110 pages).
001465083 336__ $$atext$$btxt$$2rdacontent
001465083 337__ $$acomputer$$bc$$2rdamedia
001465083 338__ $$aonline resource$$bcr$$2rdacarrier
001465083 5050_ $$aCover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- The Need for Artificial Intelligence in Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Application of Artificial Intelligence for Designing Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- USE OF NANOMATERIALS AND AI IN PRECISION DIAGNOSTICS -- PREDICTION OF PERSONALIZED DRUG POTENCY BY NANOTECHNOLOGY -- UTILIZING COMPUTATIONAL MODELLING IN NANOTHERAPEUTICS FOR TARGETING AND PERSONALIZED DOSING -- UTILIZING AI AND NANOMATERIALS FOR DRUG DOSING AND IMPROVED THERAPEUTIC EFFICACY -- EXPLOITING THE USE OF AI AND NANOTECHNOLOGY FOR PERSONALIZED GENE THERAPY -- CONCLUSION AND FUTURE PERSPECTIVE -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence and its Application in Cancer Nanomedicine -- Sweta Mohanty1, Sarbari Acharya1 and Chandana Mohanty1,* -- INTRODUCTION -- CANCER NANOMEDICINE -- ARTIFICIAL INTELLIGENCE (AI) -- ROLE OF AI IN DRUG DISCOVERY -- APPLICATION OF AI TECHNOLOGIES IN CANCER NANOMEDICINE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence-based Diagnostic Design for Precision Cancer Nanomedicine -- Ranjita Misra1,* and Malathi Sampath2 -- INTRODUCTION -- ROLE OF NANOMEDICINES IN CANCER DIAGNOSIS -- NANOMEDICINES USED FOR CANCER DIAGNOSIS -- ARTIFICIAL INTELLIGENCE AND ITS SIGNIFICANCE -- APPLICATION OF ARTIFICIAL INTELLIGENCE TOWARDS CANCER DIAGNOSIS -- ADVANTAGE OF INTEGRATION OF ARTIFICIAL INTELLIGENCE AND NANOMEDICINES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES.
001465083 5058_ $$aArtificial Intelligence-based Nanosensors to Compose the Patient's Cancer Biomarker Profile -- Malathi Sampath1 and Ranjita Misra2,* -- INTRODUCTION -- NANOSENSORS AND THEIR ROLE IN BIOMARKERS PROFILING -- TYPES OF NANOSENSORS -- Affinity Based Biosensors -- Catalytic Based Sensors -- Enzymes -- Microbes -- Organelles -- Tissue Samples -- OPTICAL NANOSENSORS -- ELECTROCHEMICAL SENSORS -- CHEMICAL NANOSENSORS -- DEPLOYABLE SENSOR -- ELECTROMETERS -- BIOSENSOR -- ADVANTAGES OF AMALGAMATION OF NANOSENSORS WITH ARTIFICIAL INTELLIGENCE -- FUTURE PERSPECTIVES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence as a Putative Tool for Newer Drug Development Approach in Cancer Nanomedicine -- Pooja Jain1, Sradhanjali Mohapatra1, Nazia Hassan1, Manvi Singh2, Uzma Farooq1, Mohd. Aamir Mirza1 and Zeenat Iqbal1,* -- INTRODUCTION -- CANCER -- Cancer Diagnosis and Treatment Approaches -- Cancer Nanomedicines -- ARTIFICIAL INTELLIGENCE -- Integration of AI and Nanotechnology for Cancer Therapy -- Artificial Intelligence-Driven Approach for Future Healthcare System -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENT -- REFERENCES -- Artificial Intelligence-Enabled Model for Predicting the Metastatic Potential of Cancer Cells -- Sarbari Acharya1,* and Chandana Mohanty1 -- INTRODUCTION -- CANCER METASTASIS -- DIAGNOSIS OF CANCER METASTASIS -- ARTIFICIAL INTELLIGENCE AND CANCER DETECTION -- ROLE OF AI MODELS FOR PREDICTING CANCER METASTASIS -- FUTURE PERSPECTIVES AND CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence for Cancer Nanotheranostics -- Sarbari Acharya1,* -- INTRODUCTION -- CANCER IMAGING -- THERANOSTICS AND NANOTHERANOSTICS -- ROLE OF NANOTHERANOSTICS IN CANCER MANAGEMENT.
001465083 5058_ $$aAI IN NANOMEDICINE FOR CANCER THERAPY -- AI AND NANOTHERANOSTICS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Ethical Dimensions of Using Artificial Intelligence in Healthcare -- Ajit Kumar Behura1,* -- INTRODUCTION -- ETHICAL CONSIDERATIONS WHEN USING AI IN HEALTH CARE -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index -- Back Cover.
001465083 506__ $$aAccess limited to authorized users.
001465083 520__ $$aNanomedicine is evolving with novel drug formulations devised for multifunctional approaches towards diagnostics ad therapeutics. Nanomedicine-based drug therapy is normally explored at a fixed dose. The drug action is time-dependent, dose-dependent and patient-specific. To overcome challenges of nanomedicine testing, artificial intelligence (AI) serves as a helping tool for optimizing the drug and dose parameters. Real time conversions between these two features enables upgradation of patient data acquisition and improved design of nanomaterials. In this scenario, AI-based pattern analysis and algorithms models can greatly improve accuracy of diagnostics and therapeutics. This book gives a comprehensive explanation of the role of machine learning and artificial intelligence in cancer nanomedicine. It presents 10 chapters that cover multiple dimensions of the subject. These dimensions are:- The need of AI and ML in designing new cancer drugs- Application of AI in cancer drug design- AI-based drug delivery models for cancer drugs- Diagnostic applications of AI- Intelligent nanosensors for biomarker profiling- Predictive models for metastatic cancer- Cancer nanotheranostics- Ethics of AI in medicine Contributions have been made by 16 researchers who are experts in pharmacology and drug design. The contents of the book bridge knowledge gaps between the fields of biomedical engineering, pharmacology and clinical medicine, with a focus on cancer treatment. The book serves as a reference for scholars learning about cancer diagnostics and therapeutics. Biomedical engineers who are involved in healthcare projects will also find the concepts and techniques highlighted in the book informative for understanding modern computer-based approaches used to solve clinical problems.
001465083 588__ $$aDescription based on publisher supplied metadata and other sources.
001465083 655_0 $$aElectronic books
001465083 7001_ $$aBehura, Ajit Kumar.
001465083 77608 $$iPrint version:$$aDilnawaz, Fahima$$tArtificial Intelligence Based Cancer Nanomedicine: Diagnostics, Therapeutics and Bioethics$$dSingapore : Bentham Science Publishers,c2022$$z9789815050578
001465083 852__ $$bebk
001465083 85640 $$3ProQuest Ebook Central Academic Complete $$uhttps://univsouthin.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/usiricelib-ebooks/detail.action?docID=7014636$$zOnline Access
001465083 909CO $$ooai:library.usi.edu:1465083$$pGLOBAL_SET
001465083 980__ $$aBIB
001465083 980__ $$aEBOOK
001465083 982__ $$aEbook
001465083 983__ $$aOnline